Dr Reddys Laboratories (RDY) Interest Coverage Ratio (2009 - 2016)

Dr Reddys Laboratories (RDY) posted quarterly Interest Coverage Ratio of 1.9 for Q4 2016, down 89.13% quarter-over-quarter from 17.5 in Q1 2013.

Dr Reddys Laboratories (RDY) Interest Coverage Ratio (2009 - 2016) Analysis & Trends

Dr Reddys Laboratories' Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 1.9 for Q4 2016.

In Q4 2016, Interest Coverage Ratio changed N/A year-over-year to 1.9; the TTM figure through Sep 2017 stood at 9.29 (changed N/A YoY), while the FY2026 annual figure was 13.48, down 47.19% from the prior year.
Interest Coverage Ratio for Q4 2016 stood at 1.9, down from 17.5 in the prior quarter.
The five-year high for Interest Coverage Ratio was 68000000.0 in Q4 2012, with the low at 1.9 in Q4 2016.
The 3-year median for Interest Coverage Ratio is 17.5 (2013), against an average of 22666673.13.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-3.15
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	114.07
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	0.05
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	52.24
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	4.20
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Alkermes	8.02 Bn	7.37 Bn	397.90 Mn	0.71

Download Data